Chenghui Huang

机构：Central South University, Lanzhou University of Technology, Third Xiangya Hospital · ORCID：0000-0003-2110-2172

发表论文 49 篇 · 总被引 826 次 · h-index 14

代表论文

• Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial (2023 · Annals of the Rheumatic Diseases · 被引 146)
• Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial (2023 · Lara D. Veeken · 被引 75)
• The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI (2020 · Cancer Imaging · 被引 70)
• Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells (2020 · Journal of International Medical Research · 被引 34)
• SiRNA targeting PFK1 inhibits proliferation and migration and enhances radiosensitivity by suppressing glycolysis in colorectal cancer. (2020 · PubMed · 被引 19)
• Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis (2021 · Frontiers in Oncology · 被引 13)